Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy

Radiotherapy and Oncology(2022)10.1016/j.radonc.2022.01.007Source: DataRank Database

Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy is a research paper published in Radiotherapy and Oncology (2022). On theSindex it has a DataRank of 0. It has been cited 69 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access69 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 5.48)OA: greenTopics (23)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Yejin Kim ORCID,Ibrahim Chamseddine ORCID,Won Hee Lee ORCID,Hye Ryun Kim ORCID,Ik Jae Lee ORCID

Live enrichment

PubMed:35033601 OpenAlex:https://openalex.org/W4206436744

National Research Foundation of Korea

Grant: NRF2020R1A2C2011959

Korea Health Industry Development Institute

Grant: HI19C1332000020

Yonsei University College of Medicine

Grant: 6-2017-0105

National Institutes of Health

Grant: R21 CA241918

National Institutes of Health

Grant: P01 CA261669

FWCI

5.48

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: cc-by-nc-nd

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9036741

publisherhttps://api.elsevier.com/content/article/PII:S0167814022000111?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167814022000111?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.radonc.2022.01.007

Fields of Study

Inflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis

MeSH Terms

Carcinoma, Non-Small-Cell LungHumansImmunotherapyLung NeoplasmsLymphocytesLymphopeniaRetrospective StudiesChemoradiotherapy

Keywords

MedicineInternal medicineLymphocyteStage (stratigraphy)OncologyRadiation therapyImmunotherapyChemoradiotherapyProportional hazards modelLung cancerGastroenterologyCancer

Sustainable Development Goals

SDG 0: Good health and well-being